190 related articles for article (PubMed ID: 35484312)
1. Interictal plasma glutamate levels are elevated in individuals with episodic and chronic migraine.
Park CG; Chu MK
Sci Rep; 2022 Apr; 12(1):6921. PubMed ID: 35484312
[TBL] [Abstract][Full Text] [Related]
2. Interictal plasma endothelin-1 levels do not change in individuals with episodic and chronic migraine.
Kim J; Park CG; Chu MK
Cephalalgia; 2022 Jul; 42(8):761-768. PubMed ID: 35166151
[TBL] [Abstract][Full Text] [Related]
3. Salivary glutamate is elevated in individuals with chronic migraine.
Nam JH; Lee HS; Kim J; Kim J; Chu MK
Cephalalgia; 2018 Jul; 38(8):1485-1492. PubMed ID: 29126354
[TBL] [Abstract][Full Text] [Related]
4. No change in interictal C-reactive protein levels in individuals with episodic and chronic migraine: A case-control study and literature review.
Park CG; Lee SH; Chu MK
Front Neurol; 2022; 13():1021065. PubMed ID: 36313504
[TBL] [Abstract][Full Text] [Related]
5. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Alvarez R; Larrosa D; Ramón C; Pascual J
Cephalalgia; 2015 Apr; 35(4):310-6. PubMed ID: 24847167
[TBL] [Abstract][Full Text] [Related]
6. Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine.
Ashina M; Cohen JM; Gandhi SK; Du E
Headache; 2021 Jun; 61(6):916-926. PubMed ID: 34115380
[TBL] [Abstract][Full Text] [Related]
7. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
8. Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen.
Cowan RP; Gross NB; Sweeney MD; Sagare AP; Montagne A; Arakaki X; Fonteh AN; Zlokovic BV; Pogoda JM; Harrington MG
Headache; 2021 Mar; 61(3):536-545. PubMed ID: 33724462
[TBL] [Abstract][Full Text] [Related]
9. Altered gut microbiota in individuals with episodic and chronic migraine.
Yong D; Lee H; Min HG; Kim K; Oh HS; Chu MK
Sci Rep; 2023 Jan; 13(1):626. PubMed ID: 36635330
[TBL] [Abstract][Full Text] [Related]
10. Trigeminal and cervical sensitization during the four phases of the migraine cycle in patients with episodic migraine.
Di Antonio S; Castaldo M; Ponzano M; Bovis F; Hugo Villafañe J; Torelli P; Finocchi C; Arendt-Nielsen L
Headache; 2022 Feb; 62(2):176-190. PubMed ID: 35122434
[TBL] [Abstract][Full Text] [Related]
11. Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache.
Han X; Dong Z; Hou L; Wan D; Chen M; Tang W; Yu S
Clin Chim Acta; 2015 Oct; 450():151-4. PubMed ID: 26296898
[TBL] [Abstract][Full Text] [Related]
12. Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2.
Mozafarihashjin M; Togha M; Ghorbani Z; Farbod A; Rafiee P; Martami F
J Headache Pain; 2022 Jan; 23(1):3. PubMed ID: 34991456
[TBL] [Abstract][Full Text] [Related]
13. Generalized Pain Sensitization and Endogenous Oxytocin in Individuals With Symptoms of Migraine: A Cross-Sectional Study.
You DS; Haney R; Albu S; Meagher MW
Headache; 2018 Jan; 58(1):62-77. PubMed ID: 29094347
[TBL] [Abstract][Full Text] [Related]
14. [Temporomandibular disorder and cervicalgia: pathophysiology underlying the comorbidity with chronic migraine].
Latysheva NV; Platonova AS; Filatova EG
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):17-22. PubMed ID: 30778026
[TBL] [Abstract][Full Text] [Related]
15. Increased serum prolactin level may indicate more migraine attack frequency.
Togha M; Nematgorgani S; Ghorbani Z; Rafiee P; Haghighi S
Brain Behav; 2023 Jul; 13(7):e3063. PubMed ID: 37190874
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid glutamate levels in chronic migraine.
Peres MF; Zukerman E; Senne Soares CA; Alonso EO; Santos BF; Faulhaber MH
Cephalalgia; 2004 Sep; 24(9):735-9. PubMed ID: 15315529
[TBL] [Abstract][Full Text] [Related]
17. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
18. Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials).
Ailani J; Andrews JS; Rettiganti M; Nicholson RA
J Headache Pain; 2020 Oct; 21(1):123. PubMed ID: 33069214
[TBL] [Abstract][Full Text] [Related]
19. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.
Serrano D; Lipton RB; Scher AI; Reed ML; Stewart WBF; Adams AM; Buse DC
J Headache Pain; 2017 Oct; 18(1):101. PubMed ID: 28980171
[TBL] [Abstract][Full Text] [Related]
20. Serum tau protein elevation in migraine: a cross-sectional case-control study.
Overeem LH; Raffaelli B; Fleischmann R; Süße M; Vogelgesang A; Maceski AM; Papadopoulou A; Ruprecht K; Su W; Koch M; Siebert A; Arkuszewski M; Tenenbaum N; Kuhle J; Reuter U
J Headache Pain; 2023 Sep; 24(1):130. PubMed ID: 37726712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
